Selection of neoadjuvant treatment based on oncotype score in luminal breast cancer

被引:0
|
作者
Gasol Cudos, A. [1 ]
Morales Murillo, S. [1 ]
Veas Rodriguez, J. [1 ]
Canosa Morales, C. [1 ]
Mele Olive, J. [1 ]
Vilardell Villellas, F. [1 ]
Sanchez Guzman, D. R. [1 ]
Iglesias Martinez, E. [1 ]
Salud Salvia, A. [1 ]
机构
[1] Hosp Univ Arnau Vilanova Lleida, Breast Canc Unit, Lleida, Spain
来源
BREAST | 2019年 / 44卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P166
引用
收藏
页码:S72 / S72
页数:1
相关论文
共 50 条
  • [21] Prediction of response to neoadjuvant chemotherapy in ER plus breast cancer: Magee equation recurrence versus oncotype DX® recurrence score
    Soran, A.
    Johnson, R.
    Menekse, E.
    Bhargava, R.
    McGuire, K.
    McAuliffe, P.
    Ahrendt, G.
    Dabbs, D.
    Bonaventura, M.
    CANCER RESEARCH, 2016, 76
  • [22] Discordance in Oncotype DX Breast Recurrence Score(R) Results for Bilateral Breast Cancer
    Bloom, Joshua A.
    Sekigami, Yurie
    Young, Rebekah
    Macera, Lisa
    Russell, Christy A.
    Cao, Yu
    Buchsbaum, Rachel J.
    Naber, Stephen P.
    Chatterjee, Abhishek
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (13) : 8711 - 8716
  • [23] 18F-Fluoroestradiol PET to Predict the Response to Neoadjuvant Treatment of Luminal Breast Cancer
    Groheux, David
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (04) : 683 - 683
  • [24] Advances in the treatment of luminal breast cancer
    Howell, Sacha J.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2013, 25 (01) : 49 - 54
  • [25] Neoadjuvant treatment in breast cancer
    Huober, J.
    ONKOLOGIE, 2011, 34 : 92 - 92
  • [26] Neoadjuvant Treatment of Breast Cancer
    Untch, Michael
    von Minckwitz, Gunter
    BREAST CARE, 2011, 6 (06) : 417 - 417
  • [27] Neoadjuvant treatment of breast cancer
    Thompson, A. M.
    Moulder-Thompson, S. L.
    ANNALS OF ONCOLOGY, 2012, 23 : 231 - 236
  • [28] Can Oncotype DX recurrence score (RS) be used in luminal A and luminal B breast cancer patients (pts) to predict the likely benefit of chemotherapy? A retrospective study in the Spanish population
    Garcia-Estevez, Laura
    Contreras, Ana C.
    Calvo, Isabel
    Fernandez Abad, Maria
    de la Cruz, Juan J.
    Perea, Sofia
    Suarez, Ana
    Lopez-Rios, Fernando
    Hidalgo, Manuel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] Efficacy of neoadjuvant endocrine therapy versus neoadjuvant chemotherapy in luminal A or luminal B breast cancer patients: Does it matter?
    Altundag, Kadri
    JOURNAL OF BUON, 2019, 24 (06): : 2581 - 2581
  • [30] Oncotype DXA® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy
    Pease, Alison M.
    Riba, Luis A.
    Gruner, Ryan A.
    Tung, Nadine M.
    James, Ted A.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (02) : 366 - 371